Everlywell to roll out home testing kits for COVID-19

March 19, 2020
Digital Transformation More...
by Danielle Bradnan
Truly disruptive

Everlywell has developed a kit for COVID-19 and will launch on March 23, 2020. This is extremely important because it allows the scientific community to get the numbers needed to effectively plan response strategies for the next 18 months – the expected timeline for vaccine distribution. Right now, due to limited access to tests, scientists and policymakers are dealing with a lot of unknowns, including the number of actual cases – as a dearth of tests means many with symptoms are simply asked to stay home to minimize the spread. Everlywell has developed a plan to support a testing capacity of a 250,000 tests per week, which means a greater availability of data, which will in turn inform the next steps in managing this pandemic.

For the original news article, click here .

Further Reading

Identifying viruses from exhaled breath is promising but may not be available before end of COVID-19 pandemic

News Commentary | October 30, 2020

Imec has started developing a new COVID‑19 testing tool that can identify COVID‑19 virus particles in patients' exhaled breath. The new method, if it works, will allow faster and more comfortable testing than the incumbent PCR and antigen tests involving nose swabbing and blood draws. Imec aims to ... Not part of subscription

Should you worry about path dependence in sustainable materials?

Analyst Insight | February 26, 2021

Companies like Conceptos Plásticos in Colombia and Gjenge Makers in Kenya have a clever solution for the problem of plastic waste pollution in the developing world: Convert discarded plastics into building materials like bricks and tiles. This elegant approach kills several birds with one stone, ... Not part of subscription

Helix partners with Ginkgo Bioworks to enable school reopening through accessible COVID-19 testing

News Commentary | April 12, 2021

Allowing schools to reopen for in‑person learning is a key step for any nation's COVID‑19 recovery roadmap. To do so, a robust, scalable, and cost‑effective COVID‑19 testing program must be implemented, alongside ongoing vaccination initiatives. Helix and Ginkgo Bioworks have joined forces to tackle... Not part of subscription